The global enzymes market size is estimated to be valued at USD 14.0 billion in 2024 and is projected to reach USD 20.4 billion by 2029, recording a CAGR of 7.8%. The biopharmaceutical industry’s rapid growth, driven by advancements in biotechnology and personalized medicine, presents significant opportunities for the enzyme market.